Ulonivirine clinical trials
Also written MK-8507.
How each study uses ulonivirine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ulonivirine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2025 (3); 1 more planned to start later
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Islatravir (4) · Methadone (1) · Atorvastatin (1) · Metformin (1) · Moxifloxacin (1)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test ulonivirine.
- Jun 2027Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)Phase 1 · Merck Sharp & Dohme LLC
- Aug 2027A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)Phase 2 · Merck Sharp & Dohme LLC
Studies
Open first, then newest update. How each study uses ulonivirine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)RecruitingPhase 2/3Merck Sharp & Dohme LLCNCT07266831Written as ULO
- Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)Not yet recruitingPhase 1Merck Sharp & Dohme LLCNCT05093972Written as Ulonivirine
- A Study of MK-8507 and Islatravir (MK-8591) in Healthy Adult Participants (MK-8507-016)CompletedPhase 1Merck Sharp & Dohme LLCNCT06619678Written as MK-8507
- A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)CompletedPhase 1Merck Sharp & Dohme LLCNCT07595263Written as Ulonivirine
- A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)CompletedPhase 1Merck Sharp & Dohme LLCNCT07530289Written as Ulonivirine
- A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)CompletedPhase 1Merck Sharp & Dohme LLCNCT07305831Written as Ulonivirine
- Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]CompletedPhase 2Merck Sharp & Dohme LLCNCT04564547Written as Ulonivirine
- A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)CompletedPhase 1Merck Sharp & Dohme LLCNCT07334886Written as [14C]Ulonivirine
- A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)Active, not recruitingPhase 2Merck Sharp & Dohme LLCNCT06891066Written as ULO
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)CompletedPhase 1Merck Sharp & Dohme LLCNCT02174159Written as Ulonivirine
Codes
What other systems call ulonivirine · ClinicalTrials.gg INT001929
- MeSH (NLM) C000723084ulonivirineOne source ClinicalTrials.gov
- UNII (FDA) 4NS011EGKZULONIVIRINEOne source FDA
- NCI Thesaurus C190365UlonivirineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000723084 | ulonivirine | One source ClinicalTrials.gov |
| UNII (FDA) | 4NS011EGKZ | ULONIVIRINE | One source FDA |
| NCI Thesaurus | C190365 | Ulonivirine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.